SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-028332
Filing Date
2020-06-04
Accepted
2020-06-04 11:31:05
Documents
2
Effectiveness Date
2020-06-04

Document Format Files

Seq Description Document Type Size
1 DEFA14A eypt-defa14a_20200623.htm DEFA14A 48854
2 GRAPHIC gnp5unxd0vic000001.jpg GRAPHIC 4729
  Complete submission text file 0001564590-20-028332.txt   56738
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51122 | Film No.: 20942307
SIC: 3826 Laboratory Analytical Instruments